- Published at
- by manilatimes.net
positive
positive
News for Avacta Group Plc (AVCT.L)
- Published at
- by manilatimes.net
positivepositive- Published at
- by globenewswire.com
neutralneutral- Published at
- by investing.com
positivepositiveAvacta and Tempus partner for AI-driven oncology drug development By Investing.com
Avacta and Tempus partner for AI-driven oncology drug development- Published at
- by globenewswire.com
neutralneutral- Published at
- by gurufocus.com
positivepositiveHalf Year 2024 Avacta Group PLC Earnings Presentation Transcript
Sep 30, 2024 / 10:00AM GMTPresentationSep 30, 2024 / 10:00AM GMT =====================Corporate Participants===================== * Christina Coughlin A- Published at
- by globenewswire.com
neutralneutralAvacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors
This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by...- Published at
- by globenewswire.com
neutralneutralAvacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
8 September 2024 Avacta Group plc (“Avacta” or “the Group” or “the Company”) Avacta to present updated clinical data on AVA6000 at the European...- Published at
- by investing.com
mixedmixedAvacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors By Investing.com
Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors- Published at
- by marketscreener.com
mixedmixedWindward wins deal; Kodal progresses at Bougouni
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ---------- Windward Ltd - Tel Aviv, Israel-based maritime predictive...- Published at
- by gurufocus.com
positivepositiveFull Year 2023 Avacta Group PLC Earnings Presentation Transcript
Apr 30, 2024 / 11:30AM GMTPresentationApr 30, 2024 / 11:30AM GMT =====================Corporate Participants===================== * Christina Coughlin * T- Published at
- by prnewswire.com
mixedmixedProtalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors
/PRNewswire / Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of...- Published at
- by prnewswire.com
mixedmixedSoft Tissue Sarcoma Pipeline Space Brims With Novel Emerging Therapies with Over 125 Key Companies Working in the Domain | DelveInsight
/PRNewswire/ -- DelveInsight's 'Soft Tissue Sarcoma Pipeline Insight – 2023' report provides comprehensive global coverage of available, marketed, and pipeline...- Published at
- by marketscreener.com
mixedmixedSUMMARY: London listings with exposure to Silicon Valley Bank
The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- FTSE... | March 13, 2023- Published at
- by marketscreener.com
mixedmixedTRADING UPDATES: hVIVO wins contract; Dev Clever cancels shares
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: -------- Newbury Racecourse PLC - Newbury, England-based racing,... | January 17, 2023- Published at
- by globenewswire.com
mixedmixedNanodiamonds Market worth USD 371.48 Million by 2030, Registering a CAGR of 12.91%
A group of research analysts from Strategic Market Research had stated that the Nanodiamonds Market accounted for up to USD 110.31 Million in 2020 & is...- Published at
- by prnewswire.com
mixedmixedGlobal COVID-19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Medical Device Pipeline Market Assessment 2020-2021 Featuring Over 120 Companies
/PRNewswire/ -- The "COVID-19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) - Medical Devices Pipeline Assessment, 2020" report has been...- Published at
- by marketscreener.com
positivepositiveAvacta : Commercial Partnership with Mologic
Partnership to accelerate CE marking of Avacta's SARS-CoV-2 rapid antigen test and support COVID-19 testing in low and middle income countries Avacta Group plc , the developer... | February 8, 2021- Published at
- by marketscreener.com
positivepositiveAvacta : Announces Collaboration Agreement With Bruker
Collaboration to evaluate the clinical utility of the high throughput bead assisted mass spectrometry test for SARS-CoV-2 infection developed with Adeptrix ... | January 28, 2021